• Policy
• 29 new drugs with 45 ingredients reimb this year
• by Lee, Tak-Sun Dec 31, 2024 05:55am

• Policy
• Yungjin Pharm wins the 1st trial against Ofev
• by Kim, Jin-Gu Dec 31, 2024 05:44am

• Policy
• K-CAB, Enteresto, Olumiant, Rinvoq signs PVA agreements
• by Lee, Tak-Sun Dec 30, 2024 05:57am

• Policy
• 7 pharmas newly win 'Innovative Pharmaceutical
• by Lee, Tak-Sun Dec 30, 2024 05:57am

• Policy
• Movizolo Tab subject to drug shortage prevention program
• by Lee, Tak-Sun Dec 27, 2024 05:56am

• Policy
• "Viread generic have saved KRW 400B in drug cost over 9 yrs"
• by Lee, Hye-Kyung Dec 27, 2024 05:56am

• Policy
• Generic verision of Citus Tab will be reimb-listed next mo.
• by Lee, Tak-Sun Dec 27, 2024 05:55am

• Policy
• MFDS' drug data protection to be implemented next year
• by Lee, Hye-Kyung Dec 24, 2024 06:22am

• Policy
• Original 'Otezla' withdraws, whereas 5 generics get listed
• by Lee, Tak-Sun Dec 23, 2024 05:50am

• Policy
• New drug approval fees to increase next year
• by Lee, Hye-Kyung Dec 23, 2024 05:50am